, ,
Presentations this author is a contributor to:
Phase 3 study COU-AA-301of abiraterone acetate (AA) plus prednisone (P) in metastatic castration-resistant prostate cancer (mCRPC): an exploratory analysis of prior docetaxel treatment and survival benefit (#154)
9:45 AM
Paul Mainwaring
COSA Best of the Best Orals: Clinical Sciences
Health resource utilisation (HRU) and patient burden associated with skeletal-related events (SREs) in a randomised controlled trial setting (#867)
3:00 PM
Gary Richardson
COSA Posters: Education and Supportive Care